2020
DOI: 10.3390/ijms21218184
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis

Abstract: Yes-associated protein (YAP) activation after acute ischemic kidney injury might be related to interstitial fibrosis and impaired renal tubular regeneration. Verteporfin (VP) is a photosensitizer used in photodynamic therapy to treat age-related macular degeneration. In cancer cells, VP inhibits TEA domain family member (TEAD)-YAP interactions without light stimulation. The protective role of VP in unilateral ureteral obstruction (UUO)-induced renal fibrosis and related mechanisms remains unclear. In this stud… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
19
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 44 publications
1
19
0
Order By: Relevance
“…Apart from the mechanical difference, DTM components differences may also influence YAP1 intracellular distribution. TGF-β1, identified in DAF-G, was reported to mediate YAP1 activation via PI3K/Akt pathway, resulting in myofibroblasts phenotype [ 74 , 75 ]. YAP1 target gene subsets were also largely dependent on endogenous TGF-β1 signaling [ 76 ].…”
Section: Discussionmentioning
confidence: 99%
“…Apart from the mechanical difference, DTM components differences may also influence YAP1 intracellular distribution. TGF-β1, identified in DAF-G, was reported to mediate YAP1 activation via PI3K/Akt pathway, resulting in myofibroblasts phenotype [ 74 , 75 ]. YAP1 target gene subsets were also largely dependent on endogenous TGF-β1 signaling [ 76 ].…”
Section: Discussionmentioning
confidence: 99%
“…Remarkably, YAP is upregulated in dystrophic mdx muscle, denervated muscle, and in hind-limbs from the SOD1G93A ALS model [ 122 , 128 ], then it is possible that YAP/TEAD can be contributing to CCN2/CTGF upregulation in fibrotic skeletal muscle, in a direct way and by crosstalking with TGF-β, LPA and hypoxia/vasculogenesis pathways. As a possible therapeutic target for kidney diseases, YAP inhibition using verteporfin effectively decreased renal fibrosis in mice, reducing TGF-β signaling and CCN2/CTGF levels [ 129 ]. Additional investigation must be performed to fully determine the contribution of YAP/TEAD on CCN2/CTGF modulation in fibrotic skeletal muscle.…”
Section: Regulation Of Ccn2/ctgf and Fibrosis In Skeletal Muscle: Role Of Vasoactive Peptidesmentioning
confidence: 99%
“…Silencing YAP in early embryonic nephron progenitor cells leads to hypoplastic kidney, and TAZ knockout mice show impairment of renal epithelial cell cilia, resulting in polycystic kidneys (17,18). In addition, YAP/TAZ inhibition by verteporfin ameliorates renal fibrosis after unilateral ureteral obstruction in adult mice (19).…”
Section: Introductionmentioning
confidence: 99%